Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "genentech"

Roche buys Genentech collaborator ForSight VISION4

Roche ( OTCQX:RHHBY ) acquires privately-held Menlo Park, CA-based ForSight VISION4, a venture capital-backed biotech developing eye drugs delivered via an intravitreal implant called PDS. The company has been collaborating with Roche's Genentech ... Seeking Alpha, 6 days ago
Roche invests in technology that could reduce injection burden American Academy of Ophthalmology, 5 days ago
[x]  

84 images for genentech

Pharma Live, 2 hours ago
Cancer Therapy Advisor, 5 days ago
Drug Development & Delivery, 8 hours ago
Xconomy, 1 week ago
Process and Control Today, 3 days ago
Nasdaq, 1 week ago
Nasdaq, 1 week ago
FOXBusiness.com, 1 week ago
BusinessInsider.sg, 1 week ago
Nasdaq, 1 week ago
Nasdaq

BRIEF-Genentech withdraws counterclaim against Exelixis in JAMS arbitration

n"Jan 9 Exelixis Inc : * Update on dispute between Exelixis and Genentech, a member of the Roche group * Exelixis relieved of $18.7 million of disputed costs * Genentech withdrew counterclaim against company in ongoing JAMS arbitration concerning ...
 Reuters UK1 week ago EXELIXIS : Update on Dispute between Exelixis and Genentech, a Member of the Roche Group  4 Traders1 week ago Update on dispute between Exelixis and Genentech  Seeking Alpha1 week ago Genentech withdraws counterclaim against Exelixis in JAMS arbitration​  Reuters UK1 week ago
[x]  

Mechanisms by which obesity impacts upon asthma

Dale T Umetsu Correspondence to Dr Dale T Umetsu, Genentech Research, South San Francisco, CA 94080, USA; umetsud{at}gene.com Received 4 July 2016 Accepted 24 August 2016 Published Online First 26 September 2016 Abstract Asthma, an ...
 British Journal of the Thorax1 week ago
Cancer Therapy Advisor

Priority Review Granted to Atezolizumab for Bladder Cancer Subtype

Share this content: The FDA has granted Priority Review to Genentech's sBLA for atezolizumab (Tecentriq) as treatment of patients with urothelial carcinoma. The U.S. Food and Drug Administration (FDA) has granted Priority Review to Genentech's ...
 Cancer Therapy Advisor5 days ago FDA approves Genentech's Lucentis for myopic choroidal neovascularization  Center Watch5 days ago Tecentriq Granted Priority Review for mUC Indication  Renal & Urology News1 week ago FDA Grants Tecentriq Priority Review for Additional Type of Advanced Bladder Cancer  Pharmscope1 week ago
[x]  
EuroInvestor

Corvus Pharmaceuticals Names Ian T. Clark, Former Genentech Chief Executive Officer, to Board of Directors

BURLINGAME, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq:CRVS) today announced the appointment of Ian T. Clark, former chief executive officer and head of North American Commercial Operations at Genentech, Inc., to ...
 4 Traders1 week ago Curevac reports another failed...  European Biotechnology4 days ago Corvus Pharmaceuticals Announces Expansion of Renal Cell Carcinoma Cohort in Ongoing Phase 1/1b Clinical Study of Lead Checkpoint Inhibitor CPI-444  BioSpace6 days ago Corvus Pharma Announces Expansion Of Renal Cell Carcinoma Cohort In Ongoing Phase I/Ib Clinical Study Of Lead Checkpoint Inhibitor CPI-444  BioSpace6 days ago
[x]  
Zacks.com

Roche Gets Priority Review for Immunotherapy Drug Tecentriq

Roche Holding AG's RHHBY Genentech announced that the FDA has accepted the company's supplemental Biologics License Application (sBLA) and granted Priority Review for cancer immunotherapy, Tecentriq, for the treatment of patients suffering from ...
 Zacks.com6 days ago
[x]  
FOXBusiness.com

Why Exelixis, Inc. Stock Zoomed Higher Today

Shares of Exelixis (NASDAQ: EXEL) ended the day up almost 15% after the company announced that its partner Genentech agreed to stop charging the biotech for some expenses under their collaboration agreement. So what More From Fool.com The two ...
 FOXBusiness.com1 week ago
Pharma Live

Genentech Dealt A Legal Blow

The Massachusetts Supreme Court ruled against California-based Genentech ( RHHBY ) in a tax case regarding manufacturing status. The suit revolved around a Massachusetts corporate excise tax statute that requires companies in the state and from ...
 Pharma Live10 hours ago Genentech Dealt a Blow From Massachusetts' Highest Court  BioSpace15 hours ago
Process and Control Today

Ensuring Robust Lyophilization Scale-Up: SP Scientific announces the on-demand availability of a popular webinar

SP Scientific announces the on-demand availability of a popular webinar** by Jake Luoma of Genentech Inc. that discusses how controlled nucleation has emerged as a technology which promises improvements in lyophilization process throughput and ...
 Process and Control Today3 days ago

Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)

† Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, United States‡ Pharmaron Beijing Co., Ltd. 6 Taihe Road, BDA, Beijing 100176, P.R. China§ Manfred Eigen Campus, Evotec AG, Essener Bogen, 22419 Hamburg, Germany∥ Evotec ...
 Journal of Medicinal Chemistry4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less